Evidence map›Paper›PMID 41906633›Full record

ArticleChemistryOpen2026

From Design to Bioactivity: 2-Benzoylpyridine 4-(bicyclo[2.2.1]hept-2-yl)thiosemicarbazone and Its 3d Metal Coordination Compounds.

Ianina Graur, Vasilii Graur, Elena Melnic, Carolina Lozan-Tirsu, Greta Balan, Victor Tsapkov, Aurelian Gulea

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ChemistryOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ianina GraurLaboratory of Advanced Materials in Biopharmaceutics and Technics, Institute of Chemistry, Moldova State University, Chisinau, Republic of Moldova.ORCID https://orcid.org/0000-0002-3345-7539
Vasilii GraurLaboratory of Advanced Materials in Biopharmaceutics and Technics, Institute of Chemistry, Moldova State University, Chisinau, Republic of Moldova.ORCID https://orcid.org/0000-0001-8153-2153
Elena MelnicLaboratory of Physical Methods for Studying Solids "Tadeusz Malinowski", Institute of Applied Physics, Moldova State University, Chisinau, Republic of Moldova.ORCID https://orcid.org/0000-0003-0212-3445
Carolina Lozan-TirsuDepartment of Preventive Medicine, State University of Medicine and Pharmacy "Nicolae Testemitanu", Chisinau, Republic of Moldova.ORCID https://orcid.org/0000-0003-3831-2758
Greta BalanDepartment of Preventive Medicine, State University of Medicine and Pharmacy "Nicolae Testemitanu", Chisinau, Republic of Moldova.
Victor TsapkovLaboratory of Advanced Materials in Biopharmaceutics and Technics, Institute of Chemistry, Moldova State University, Chisinau, Republic of Moldova.ORCID https://orcid.org/0000-0003-1732-3116
Aurelian GuleaLaboratory of Advanced Materials in Biopharmaceutics and Technics, Institute of Chemistry, Moldova State University, Chisinau, Republic of Moldova.ORCID https://orcid.org/0000-0003-2010-7959

Funding

Agenţia Naţională pentru Cercetare şi Dezvoltare 24.80012.5007.14TCInstitutional Project 010602Institutional Project 011202
6 · The paper itself

Abstract

The new 2-benzoylpyridine 4-(bicyclo[2.2.1]hept-2-yl)thiosemicarbazone (HL) and its copper(II), nickel(II), cobalt(III), and iron(III) coordination compounds [Cu(L)Cl] (1), [Cu(L)NO

Indexed as

3d metal complexesantibacterial activityantifungal activitythiosemicarbazone

Identifiers

PMID41906633
PMCPMC13140696

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.